title: New evidence in oncologic and cardiocirculatory medicine.
authors.affiliation: Department of Critical Care Medicine and Surgery, University of Florence and Don Carlo Gnocchi Foundation, IRCCS Florence, Viale Morgagni 85, 50134, Florence, Italy. aa.conti@dac.unifi.it
authors.forename: Andrea Alberto
authors.initials: AA
authors.lastname: Conti
authors.forename: Beatrice
authors.initials: B
authors.lastname: Dilaghi
authors.forename: Pietro Amedeo
authors.initials: PA
authors.lastname: Modesti
authors.forename: Carlo
authors.initials: C
authors.lastname: Nozzoli
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D001943:Breast Neoplasms / Q000175:diagnosis; D002309:Cardiology; D003936:Diagnosis, Computer-Assisted; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008327:Mammography; D008495:Medical Oncology; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D008558:Melphalan; D011241:Prednisone